Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that, on average, the recipients experienced measurable improvements in typical ...

This year’s Nobel Prize in Physiology or Medicine goes to William ... New methods for deriving macrophages from induced pluripotent stem cells are easier to scale and provide more clinically relevant ...

A surgeon sues the Nobel Assembly for excluding him from last year’s prize awarded for regenerative science ... New methods for deriving macrophages from induced pluripotent stem cells are easier to ...

or induced pluripotent stem cells, for the first time. This is expected to pave the way for their use in human transplants. The 37-year-old is optimistic his Ig Nobel Prize-winning research will ...

Induced pluripotent stem cells ... Yamanaka Shin’ya, one of the lead researchers, won a Nobel Prize in 2012 for his work on these stem cells, which, thanks to their ability to generate any ...

a CiRA professor who studies Parkinson’s disease treatments using induced pluripotent stem (iPS) cells, will become the next CiRA director. Yamanaka, who won the Nobel Prize in Physiology or ...

Induced pluripotent stem cells (iPSCs) can differentiate into a number of cell types, which could be exceptionally valuable for those developing therapies. Yamanaka received the Nobel Prize in ...

Gurdon got the Nobel prize in physiology and medicine together with Shinya ... mouse cells can be reprogrammed back to a pluripotent state, to induced pluripotent stem cells or iPS cells. Since the ...

Keio University doctors said they have taken a promising step toward using human induced pluripotent stem (iPS) cells to treat spinal cord injuries.

Epigenetic reprogramming holds promise for reversing aging, addressing cellular aging mechanisms and paving the way for innovative therapeutic strategies.